Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing

Frontiers in Pharmacology

Pharmacology

Václav Trojan¹  Nikola Štefelová²  Tibor Béres²  Petr Tarkowski³  Sanja Ćavar Zeljković³  Dominika Kaczorová⁴  Pavel Klouček⁵  Anežka Kosmáková Janatová⁵  Jaroslav Peč⁶ 

[1] Cannabis Facility, Centre for Translational Medicine, International Clinical Research Centre, St. Anne’s University Hospital, Brno, Czechia;Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czechia;Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czechia;Department of Genetic Resources for Vegetables, Medicinal and Special Plants, Centre of the Region Haná for Biotechnological and Agricultural Research, Crop Research Institute, Olomouc, Czechia;Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czechia;Department of Genetic Resources for Vegetables, Medicinal and Special Plants, Centre of the Region Haná for Biotechnological and Agricultural Research, Crop Research Institute, Olomouc, Czechia;Department of Biochemistry, Faculty of Science, Palacký University, Olomouc, Czechia;Department of Food Science, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Prague, Czechia;Pharm & Herb s. r. o, Prostějov, Czechia;

关键词: Cannabis sativa;    medical cannabis;    phytocannabinoid;    galenic preparation;    extract;    stability;    dermatology;    topical application;   

DOI  :  10.3389/fphar.2023.1230728

 received in 2023-06-05, accepted in 2023-07-21,  发布年份 2023

来源: Frontiers

【 摘 要 】

Although medical cannabis was legalized in Czechia in 2013 and its use in topical treatments of skin disorders is now allowed, galenic formulations prepared from medical cannabis have not been widely implemented in the Czech healthcare system. One of the main reasons is the lack of a straightforward standardized protocol for their preparation. Cannabinoids, e.g., cannabidiol (CBD) and tetrahydrocannabinol (THC), have been shown to have therapeutic effects on various skin conditions, such as atopic dermatitis, psoriasis, scleroderma, acne and skin pigmentation. Recognizing the potential of dermatological treatment with medical cannabis, the present study aimed to evaluate the extraction capacity of various pharmaceutical bases for cannabinoids and the stability of prepared galenic formulations for dermatological applications with respect to cannabinoid content. The results showed that the stability of cannabinoids in formulations depended on the bases’ physical and chemical properties. The highest THC decomposition was observed in cream bases and Vaseline, with estimated percentage loss of total content of up to 5.4% and 5.6% per week, respectively. In contrast, CBD was more stable than THC. Overall, the tested bases were comparably effective in extracting cannabinoids from plant material. However, olive oil and Synderman bases exhibited the highest cannabinoid extraction efficiencies (approximately 70%) and the best storage stabilities in terms of the content of monitored compounds. The proposed preparation protocol is fast and easily implementable in pharmacies and medical facilities.

【 授权许可】

Unknown   
Copyright © 2023 Kaczorová, Peč, Béres, Štefelová, Ćavar Zeljković, Trojan, Janatová, Klouček and Tarkowski.